One-hundred nebulizer trials were performed in 98 adult patients with chronic airflow
limitation who had remained symptomatic despite regular use of bronchodilators by metered …

In steroid resistant chronic obstructive pulmonary disease (COPD) we assessed the effect of
qid domiciliary nebulized fenoterol (F) 1.25 mg and ipratropium (I) 0.5 mg for three weeks in …

Forty-nine patients (15 asthma, mean FEV 1/FVC 1· 3/2· 1; 34 COPD, mean FEV 1/FVC0·
7/1· 8) were referred for consideration of home nebulizer treatment. All were monitored for 2 …

Nineteen patients (12 men) mean age, 63.4 years (range, 32 to 78), with stable chronic
airflow limitation, mean FEV 1, 0.55 L (range, 0.3 to 1.05 L), completed an eight-week …

The role of short-term tests of reversibility in selecting patients with COAD for long-term
nebuliser therapy is uncertain. In a double-blind placebo-controlled crossover study we …

Nebulized bronchodilators are commonly used in the management of patients with airflow
obstruction, although there is little information available on the bronchodilator output from …

The respiratory drugs that may be given by nebuliser include not only the 1B
sympathomimetic agonists and anticholinergics but also disodium cromoglycate,'surface …

Twenty patients (six severe asthma, 14 chronic obstructive pulmonary disease, COPD) were
referred forconsideration of domiciliary nebulized treatment. A double blind laboratory …

Although home nebulizers are widely used to deliver bronchodilator medication to patients
with asthma and chronic obstructive pulmonary disease (COPD), the long-term benefits and …

Patients with severe chronic airways obstruction often respond poorly to inhaled salbutamol
in conventional dosage from a pressurized aerosol. We have investigated the response to …